Status:
UNKNOWN
Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia
Lead Sponsor:
University Hospital, Angers
Collaborating Sponsors:
French Innovative Leukemia Organisation
Conditions:
Adult Acute Lymphoblastic Leukemia
Eligibility:
All Genders
15-59 years
Brief Summary
Adult acute lymphoblastic leukemia treatment approaches relie on risk stratification, including cytogenetics. We want to study at diagnosis several blast cells parameters on frozen samples of GRAALL p...
Eligibility Criteria
Inclusion
- All GRAALL 2003 and 2005 enrolled patients with available frozen blast cells
Exclusion
- None
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
End Date :
September 1 2005
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00188084
Start Date
November 1 2003
End Date
September 1 2005
Last Update
October 28 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRLCC Centre Paul Papin
Angers, France, 49933